Christopher P. Day

1990–2024 年に発表

128
論文数
48,831
被引用数
103
h 指数
128
i10 指数

被引用数

Christopher P. Day の年別被引用数1978 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 9 件1993 年: 被引用 10 件1994 年: 被引用 38 件1995 年: 被引用 25 件1996 年: 被引用 26 件1997 年: 被引用 28 件1998 年: 被引用 52 件1999 年: 被引用 72 件2000 年: 被引用 104 件2001 年: 被引用 136 件2002 年: 被引用 176 件2003 年: 被引用 171 件2004 年: 被引用 178 件2005 年: 被引用 208 件2006 年: 被引用 205 件2007 年: 被引用 215 件2008 年: 被引用 288 件2009 年: 被引用 285 件2010 年: 被引用 398 件2011 年: 被引用 412 件2012 年: 被引用 424 件2013 年: 被引用 563 件2014 年: 被引用 582 件2015 年: 被引用 690 件2016 年: 被引用 686 件2017 年: 被引用 633 件2018 年: 被引用 543 件2019 年: 被引用 1,761 件2020 年: 被引用 1,988 件2021 年: 被引用 2,050 件2022 年: 被引用 1,605 件2023 年: 被引用 1,132 件2024 年: 被引用 1,709 件2025 年: 被引用 788 件2026 年: 被引用 26 件1979〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,128 件、この内訳の 21.2%中国: 引用元論文 2,477 件、この内訳の 12.7%イギリス: 引用元論文 1,488 件、この内訳の 7.6%イタリア: 引用元論文 1,265 件、この内訳の 6.5%ドイツ: 引用元論文 858 件、この内訳の 4.4%日本: 引用元論文 719 件、この内訳の 3.7%スペイン: 引用元論文 640 件、この内訳の 3.3%フランス: 引用元論文 625 件、この内訳の 3.2%韓国: 引用元論文 577 件、この内訳の 3%オーストラリア: 引用元論文 487 件、この内訳の 2.5%カナダ: 引用元論文 451 件、この内訳の 2.3%スウェーデン: 引用元論文 381 件、この内訳の 1.9%
0%21.2%その他 27.7%

分野

  • Medicine80.4%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Pharmacology, Toxicology and Pharmaceutics5.8%
  • Immunology and Microbiology1.3%
  • Nursing0.7%
  • Neuroscience0.6%
  • その他1.6%

トピック

  • Liver Disease Diagnosis and Treatment24.1%
  • Diet, Metabolism, and Disease6%
  • Liver Disease and Transplantation5.9%
  • Alcohol Consumption and Health Effects4.5%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.2%
  • Liver Diseases and Immunity2.6%
  • その他53.7%

共著者

全論文

検索で開く
  1. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Homie Razavi - Journal of Hepatology 2018 被引用: 2,008

  2. The NAFLD fibrosis score

    著者: , , , , , , , , , , , , , , , , - Hepatology 2007 被引用: 3,200

  3. Steatohepatitis: A tale of two “hits”?

    著者: , - Gastroenterology 1998 被引用: 4,287

  4. Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

    著者: , - New England Journal of Medicine 2017 被引用: 1,307

  5. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis

    著者: , , , , , , , , , , , , , , , - The American Journal of Gastroenterology 2016 被引用: 891

  6. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

    著者: , , - Nature Reviews Gastroenterology & Hepatology 2013 被引用: 1,753

  7. Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 454

  8. Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 514

  9. Nonalcoholic fatty liver disease

    著者: , , , , , , , , , - Nature Reviews Disease Primers 2015 被引用: 841

  10. Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

    著者: , , - New England Journal of Medicine 2010 被引用: 1,904

  11. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hannes Hagström, Camilla Akbari, Masashi Hirooka, Wah‐Kheong Chan, Sanjiv Mahadeva, Ruveena Bhavani Rajaram, Ming‐Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Viganò, Sofia Ridolfo, Guruprasad P. Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Lédinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Céline Fournier‐Poizat, Andreas Geier, Miljen Martić, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Beate K. Straub, Toni Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas ほか 130 名 - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 187

  12. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

    著者: , , , , , - Journal of Hepatology 2014 被引用: 1,049

  13. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease

    著者: , , , , - Gut 2010 被引用: 945

  14. Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum

    著者: , , , - Annual Review of Pathology Mechanisms of Disease 2016 被引用: 623

  15. An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marta B. Afonso, Ramy Younes, Yuichiro Amano, Scott L. Friedman, Shuang Wang, Dipankar Bhattacharya, Eric J. Simon, Valérie Paradis, Alastair D. Burt, Ioanna Maria Grypari, Susan Davies, Ann Driessen, Hiroaki Yashiro, Susanne Elisabeth Pors, M Andersen, Michael Feigh, Carla Yunis, Pierre Bédossa, Michelle Stewart, Heather Cater, Sara Wells, Jörn M. Schattenberg, Quentin M. Anstee, The LITMUS Investigators, Quentin M. Anstee, Ann K. Daly, Simon Cockell, Dina Tiniakos, Pierre Bédossa, Alastair D. Burt, Fiona Oakley, Heather J. Cordell, Christopher P. Day, Kristy Wonders, Paolo Missier, Matthew McTeer, Luke Vale, Yemi Oluboyede, Matt Breckons, Jo Boyle, Patrick M. Bossuyt, Hadi Zafarmand, Yasaman Vali, Jenny Lee, Max Nieuwdorp, Adriaan G. Holleboom, Athanasios Angelakis, Joanne Verheij, Vlad Ratziu, Karine Clément, Rafael Patiño‐Navarrete, Raluca Pais, Valérie Paradis, Detlef Schuppan, Jörn M. Schattenberg, Rambabu Surabattula, Sudha Rani Myneni, Yong Ook Kim, Beate K. Straub, Antonio Vidal-Puig, Michèle Vacca, Sergio Rodrigues-Cuenca, Mike Allison, Ioannis Kamzolas, Evangelia Petsalaki, Mark Campbell, Chris Lelliott, Susan Davies, Matej Orešič, Tuulia Hyötyläinen ほか 138 名 - Nature Metabolism 2024 被引用: 229

  16. Prednisolone or Pentoxifylline for Alcoholic Hepatitis

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 755

  17. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma

    著者: , , , , , , , , , - Journal of Hepatology 2014 被引用: 534

  18. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , - Nature Communications 2014 被引用: 617

  19. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 被引用: 160

  20. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

    著者: , , , , , , , - Gut 2011 被引用: 515

  21. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review

    著者: , , - Journal of Hepatology 2011 被引用: 523

  22. Simple Noninvasive Systems Predict Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

    著者: , , , , , , , , - Gastroenterology 2013 被引用: 507

  23. Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease†

    著者: , , , , , , , , , , , , , , - Hepatology 2010 被引用: 649

  24. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

    著者: , , , , , , , , , , , - Hepatology 2007 被引用: 740